학술논문
Safety and immunogenicity of 3 formulations of a Sabin inactivated poliovirus vaccine produced on the PER.C6® cell line: A phase 2, double-blind, randomized, controlled study in infants vaccinated at 6, 10 and 14 weeks of age.
Document Type
Article
Author
Source
Human Vaccines & Immunotherapeutics; 2022, Vol. 18 Issue 5, p1-11, 11p
Subject
Language
ISSN
21645515